Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Undergraduate: Summer Studentship Award - Institute Community Support

University of Ottawa

$5,000.00

Sensitivity analysis of cancer-killing virus models to improve therapeutic outcomes

FY 2014-15

Summary
Oncolytic viruses (OVs) are promising anti-tumour therapeutics that specifically infect and destroy cancer cells. Great effort is allocated to OVs in clinical trials, and to research in Canada and aboard that can further improve their therapeutic potential. To enhance the potential of OV-based cancer treatments, Drs. Kaern and Diallo use computational biology methods to identify potential strategies that can increase the cancer-specificity of OV and allow them to evade anti-viral defences. This approach analyzes mathematical models of interactions between viruses, normal and cancerous tissues, and immunity systems. This project focuses on identifying interactions that can be targeted by drugs to sensitize cancer cells to OV infection while leaving normal cells intact. This goal will be reached by conducting what in mathematics is known as a sensitivity analysis, which quantifies how much a model output (e.g., the rate of cell death) is affected by variation in model parameters (e.g., infection rates). The idea is that the parameters that are the most sensitive to variation are also the parameters that should be targeted to achieve optimal outcomes. We anticipate that the parameters identified by the proposed analysis will represent biological processes that can be targeted by therapeutic means. As cancer is the leading cause of death in the Canadian population, Dr. Diallo is committed to explore the feasibility of subsequent experiment testing of the model predictions. Even if no viable therapeutic strategy is identified, the proposed research will improve the understanding of the cause-effects relationships within an experimentally validated model of OV dynamics. As demonstrated in past collaborative work published by Drs. Kaern and Diallo in Nature Communications, these relationships have significant and direct implications for the design of novel OVs and for understanding how therapeutic outcomes can improve by combining OVs and drug treatment.
Program
Undergraduate: Summer Studentship Award - Institute Community Support
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
324063
Name
Irani Johnathon J
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Cancer Research
Theme2
Clinical
Prcname2
Undergraduate Studentship - IG
Projecttitle
Sensitivity analysis of cancer-killing virus models to improve therapeutic outcomes
Programtype2
Studentship Programs
Orgnameinp2
University of Ottawa
Cihramount2
$5,000
Cihrequipment2
$0
Programname2
Undergraduate: Summer Studentship Award - Institute Community Support
Keyworddelim
Ics Studentship
Abstract
Oncolytic viruses (OVs) are promising anti-tumour therapeutics that specifically infect and destroy cancer cells. Great effort is allocated to OVs in clinical trials, and to research in Canada and aboard that can further improve their therapeutic potential. To enhance the potential of OV-based cancer treatments, Drs. Kaern and Diallo use computational biology methods to identify potential strategies that can increase the cancer-specificity of OV and allow them to evade anti-viral defences. This approach analyzes mathematical models of interactions between viruses, normal and cancerous tissues, and immunity systems. This project focuses on identifying interactions that can be targeted by drugs to sensitize cancer cells to OV infection while leaving normal cells intact. This goal will be reached by conducting what in mathematics is known as a sensitivity analysis, which quantifies how much a model output (e.g., the rate of cell death) is affected by variation in model parameters (e.g., infection rates). The idea is that the parameters that are the most sensitive to variation are also the parameters that should be targeted to achieve optimal outcomes. We anticipate that the parameters identified by the proposed analysis will represent biological processes that can be targeted by therapeutic means. As cancer is the leading cause of death in the Canadian population, Dr. Diallo is committed to explore the feasibility of subsequent experiment testing of the model predictions. Even if no viable therapeutic strategy is identified, the proposed research will improve the understanding of the cause-effects relationships within an experimentally validated model of OV dynamics. As demonstrated in past collaborative work published by Drs. Kaern and Diallo in Nature Communications, these relationships have significant and direct implications for the design of novel OVs and for understanding how therapeutic outcomes can improve by combining OVs and drug treatment.
Competitiondate
201501
Approvedterm2
0 yr 4 mths
Pinamesdelim
Irani, Johnathon J
Approvedterm
0 an 4 mois
Cihrcontribution2
Institute of Genetics~ $5,000~ $0~